243 related articles for article (PubMed ID: 15968685)
21. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Windschall A; Ott OJ; Sauer R; Strnad V
Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
[TBL] [Abstract][Full Text] [Related]
22. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
Yokoyama Y; Takano T; Nakahara K; Shoji T; Sato H; Yamada H; Yaegashi N; Okamura K; Kurachi H; Sugiyama T; Tanaka T; Sato A; Tase T; Mizunuma H
Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
[TBL] [Abstract][Full Text] [Related]
23. Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area.
Franckena M; De Wit R; Ansink AC; Notenboom A; Canters RA; Fatehi D; Van Rhoon GC; Van Der Zee J
Int J Hyperthermia; 2007 Aug; 23(5):443-50. PubMed ID: 17701535
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
25. Role of chemoradiotherapy in advanced carcinoma cervix.
Mitra D; Ghosh B; Kar A; Basu S; Deb AR; Sur PK
J Indian Med Assoc; 2006 Aug; 104(8):432, 434, 436 passim. PubMed ID: 17240799
[TBL] [Abstract][Full Text] [Related]
26. External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma.
Petera J; Odrázka K; Frgala T; Spacek J
Gynecol Oncol; 2005 Nov; 99(2):334-8. PubMed ID: 16023181
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
Benedetti Panici P; Bellati F; Manci N; Pernice M; Plotti F; Di Donato V; Calcagno M; Zullo MA; Muzii L; Angioli R
Ann Surg Oncol; 2007 Sep; 14(9):2643-8. PubMed ID: 17562114
[TBL] [Abstract][Full Text] [Related]
29. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
[TBL] [Abstract][Full Text] [Related]
30. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
[TBL] [Abstract][Full Text] [Related]
31. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
32. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.
Pötter R; Dimopoulos J; Bachtiary B; Sissolak G; Klos B; Rheinthaller A; Kirisits C; Knocke-Abulesz TH
Radiother Oncol; 2006 Apr; 79(1):80-6. PubMed ID: 16516316
[TBL] [Abstract][Full Text] [Related]
33. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS
Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
[TBL] [Abstract][Full Text] [Related]
34. Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervix.
Nagai N; Kaneyasu Y; Komatsu M; Shiroyama Y; Oshita T; Watasaki S; Ito K
Oncol Rep; 2009 Mar; 21(3):585-91. PubMed ID: 19212615
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
Kodaira T; Fuwa N; Nakanishi T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Inokuchi H
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):251-8. PubMed ID: 18513885
[TBL] [Abstract][Full Text] [Related]
36. [Hyperthermia in combination with chemotherapy in gynecological cancers].
Rietbroek RC; Schilthuis MS; van der Zee J; González González D
Ned Tijdschr Geneeskd; 1999 Jan; 143(2):85-8. PubMed ID: 10086110
[TBL] [Abstract][Full Text] [Related]
37. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
[TBL] [Abstract][Full Text] [Related]
39. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
